evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

15 questions · 15 findings · 1 reviews

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 7 · 46.7%GRADE not reported 0 · 0%Very low 3 · 20%Low 3 · 20%Moderate 2 · 13.3%High 0 · 0%

IVIg vs SCIg

Induction of labour · people with multifocal motor neuropathy

The review found no eligible studies for this question.

1 finding from 1 review

IVIg vs SCIg

Proportion of IVIg‐treated participants with an increase in disability during controlled IVIg withdrawal · people with multifocal motor neuropathy

The review found no eligible studies for this question.

1 finding from 1 review

IVIg vs SCIg

Adverse events · people with multifocal motor neuropathy

The review found no eligible studies for this question.

1 finding from 1 review

IVIg vs SCIg

Proportion of participants with side effects attributable to treatment · people with multifocal motor neuropathy

It is very uncertain whether IVIg changes proportion of participants with side effects attributable to treatment compared with SCIg (very low certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of participants with an improvement in disability scale used in the original study · people with multifocal motor neuropathy

IVIg showed no clear difference in proportion of participants with an improvement in disability scale… compared with placebo (low certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of participants with an improvement of muscle strength · people with multifocal motor neuropathy

IVIg may leads to higher proportion of participants with an improvement of muscle strength compared with placebo (low certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of participants with an improvement in disability at 12 months or later · people with multifocal motor neuropathy

The review found no eligible studies for this question.

1 finding from 1 review

IVIg vs placebo

Proportion of participants in which at least 1 conduction block resolved after therapy · people with multifocal motor neuropathy

IVIg showed no clear difference in proportion of participants in which at least 1 conduction block… compared with placebo (low certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of IVIg‐treated participants with an increase in disability during controlled IVIg withdrawal · people with multifocal motor neuropathy

IVIg probably leads to higher proportion of IVIg‐treated participants with an increase in… compared with placebo (moderate certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of IVIg‐treated participants with a decrease in muscle strength during controlled IVIg withdrawal · people with multifocal motor neuropathy

IVIg probably leads to lower proportion of IVIg‐treated participants with a decrease in muscle… compared with placebo (moderate certainty).

1 finding from 1 review

IVIg vs placebo

Proportion of participants with side effects attributable to treatment · people with multifocal motor neuropathy

It is very uncertain whether IVIg changes proportion of participants with side effects attributable to treatment compared with placebo (very low certainty).

1 finding from 1 review